ACCC pushes back pharma decision again
Thursday, 28 October 2010
Faaez Samadi
The Australian Competition and Consumer Commission (ACCC) has extended its review of the proposed merger between pharmaceutical company Aspen Pharmacare Holdings and rival Sigma Pharmaceuticals.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top